{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:49:51Z","timestamp":1784868591284,"version":"3.55.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>A profound mismatch between biological and symptom control in acromegaly creates a high disease burden despite achieving optimal biological control. There is a great need to learn more about the perspectives of patients living with acromegaly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Acromegaly Community hosted a virtual meeting in January 2021 and prepared a detailed report capturing participants\u2019 input on acromegaly symptoms and current and future treatment approaches. The findings of this report are reviewed and summarized in this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fatigue\/muscle weakness (92%) and joint pain\/arthritis (90%) are the two most common and troublesome symptoms reported by meeting participants. Acromegaly negatively impacts all aspects of daily living: social interaction (49%); exercise (42%); sports\/recreational activities (39%); household activities (38%); attending school or job (38%); family relationships (33%); and walking (26%). Anxiety\/depression is experienced by 75% of respondents. Eighty-three percent of patients underwent pituitary surgery, and over 71% of patients require medical therapy. Patients desire future improvements in medication efficacy, tolerability, and administration; mental health resources for themselves and their families; and other multimodal approaches to address their physical symptoms, specifically hunger, weight gain, muscle weakness, and joint pains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Acromegaly patients experience significant physical and psychological burdens despite biochemical control, highlighting the need for comprehensive and patient-centered care. In particular, the impacts on activities of daily living (ADLs) and heavy psychosocial and socioeconomic burdens are striking. We advocate for periodic screening for impacted ADLs, multidisciplinary teams to proactively address these symptoms, and call for further research on under-evaluated aspects of the disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1516131","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T05:12:30Z","timestamp":1738559550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Patient perspectives on acromegaly disease burden: insights from a community meeting"],"prefix":"10.3389","volume":"16","author":[{"given":"Shruti N.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C. J.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Bonert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Sisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystal","family":"Palaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Dancel-Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvad097","article-title":"The socioeconomic burden of acromegaly","volume":"189","author":"St\u00f6rmann","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed","year":"2009","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S38594","article-title":"Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment","volume":"6","author":"Adelman","year":"2013","journal-title":"Int J Gen Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-22-0263","article-title":"Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study","volume":"187","author":"Pivonello","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0887-1","article-title":"Cognitive-behavioral therapy improves the quality of life of patients with acromegaly","volume":"21","author":"Kunzler","year":"2018","journal-title":"Pituitary"},{"key":"B6","doi-asserted-by":"publisher","first-page":"bvab061","DOI":"10.1210\/jendso\/bvab061","article-title":"The need for patient-centered education among patients newly diagnosed with a pituitary tumor","volume":"5","author":"Donegan","year":"2021","journal-title":"J Endocr Soc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0725-2","article-title":"Challenges in the diagnosis and management of acromegaly: a focus on comorbidities","volume":"19","author":"Abreu","year":"2016","journal-title":"Pituitary"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01782-x","article-title":"Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management","volume":"45","author":"Camerini","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-01013-2","article-title":"Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider","volume":"23","author":"Geer","year":"2020","journal-title":"Pituitary"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01381-4","article-title":"Different patient versus provider perspectives on living with Cushing\u2019s disease","volume":"27","author":"Halstrom","year":"2024","journal-title":"Pituitary"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0636-7","article-title":"Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas","volume":"69","author":"Van Der Klaauw","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0236-8","article-title":"Perception of health and cognitive dysfunction in acromegaly patients","volume":"46","author":"Crespo","year":"2014","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1071","article-title":"Virtual education programming for patients with acromegaly: a pilot study","volume":"186","author":"Geer","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40900-018-0093-3","article-title":"Enhancing the incorporation of the patient\u2019s voice in drug development and evaluation","volume":"4","author":"Chalasani","year":"2018","journal-title":"Res Involv Engagem"},{"key":"B16","unstructured":"Voice of the patient: living with acromegaly\n          \n          \n            \n              Sisco\n              J\n            \n            \n              Palaty\n              C\n            \n          \n          \n          2024"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/0142159X.2020.1755030","article-title":"Thematic analysis of qualitative data: AMEE Guide No. 131","volume":"42","author":"Kiger","year":"2020","journal-title":"Med Teach"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.2008.292","article-title":"Analysing and presenting qualitative data","volume":"204","author":"Burnard","year":"2008","journal-title":"Br Dent J"},{"key":"B19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-90-481-9485-8_6","article-title":"Patient registries: utility, validity and inference","volume-title":"Rare Diseases Epidemiology","author":"Richesson","year":"2010"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0171.x","article-title":"Brief report: The prevalence and use of chronic disease registries in physician organizations","volume":"20","author":"Schmittdiel","year":"2005","journal-title":"J Gen Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a\u00a0nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0845","article-title":"High prevalence of arthropathy, according to the definitions of\u00a0radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study","volume":"160","author":"Wassenaar","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2297","article-title":"Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life","volume":"90","author":"Biermasz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0120","article-title":"Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up","volume":"177","author":"F\u00fcchtbauer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12902-020-00595-4","article-title":"Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice","volume":"20","author":"Geer","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B27","doi-asserted-by":"publisher","first-page":"bvad104","DOI":"10.1210\/jendso\/bvad104","article-title":"Treatment patterns, adherence, persistence, and health care resource utilization in acromegaly: A real-world analysis","volume":"7","author":"Fleseriu","year":"2023","journal-title":"J Endocr Soc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","article-title":"Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States","volume":"25","author":"Fleseriu","year":"2022","journal-title":"Pituitary"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212153-00008","article-title":"Treatment-related factors and highly active antiretroviral therapy adherence","volume":"31","author":"Trotta","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S268499","article-title":"Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions","volume":"14","author":"Elnaem","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00229","article-title":"Health outcomes in acromegaly: depression and anxiety are promising targets for improving reduced quality of life","volume":"5","author":"Geraedts","year":"2015","journal-title":"Front Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad237","article-title":"Psychopathology in acromegaly-real and perceived","volume":"108","author":"Pivonello","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-023-01376-7","article-title":"Acromegaly increases depressive symptoms and reduces quality of life of cohabitants","volume":"27","author":"Uysal","year":"2024","journal-title":"Pituitary"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0447-z","article-title":"Diagnostic delay is associated with psychosocial impairment in acromegaly","volume":"16","author":"Siegel","year":"2013","journal-title":"Pituitary"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0019","article-title":"Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality","volume":"182","author":"Esposito","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","article-title":"Consensus on criteria for acromegaly diagnosis and remission","volume":"27","author":"Giustina","year":"2024","journal-title":"Pituitary"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2022.04.004","article-title":"Evaluating the impact of acromegaly on quality of life","volume":"51","author":"Coopmans","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4158\/EP161373.OR","article-title":"Predictors of quality of life in 165 patients with acromegaly: results from a single-center study","volume":"23","author":"Kreitschmann-Andermahr","year":"2017","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/PPA.S56740","article-title":"Patient perspectives on the impact of acromegaly: results from individual and group interviews","volume":"8","author":"Gurel","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1565","article-title":"Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire","volume":"90","author":"Rowles","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0860-4","article-title":"How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review","volume":"21","author":"Andela","year":"2018","journal-title":"Pituitary"},{"key":"B43","doi-asserted-by":"publisher","first-page":"101309","DOI":"10.1016\/j.beem.2019.101309","article-title":"The burden of disease for pituitary patients","volume":"33","author":"Biermasz","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2018.1465131","article-title":"The relationship between employment and health and health care among working-age adults with and without disabilities in the United States","volume":"41","author":"Reichard","year":"2019","journal-title":"Disabil Rehabil"},{"key":"B45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11524-011-9625-y","article-title":"Social stability and health: exploring multidimensional social disadvantage","volume":"89","author":"German","year":"2012","journal-title":"J Urban Health Bull N Y Acad Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14392","article-title":"Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature","volume":"94","author":"Dal","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1046\/j.1523-5394.1999.07206.x","article-title":"Gender and cancer support group participation","volume-title":"Cancer Pract","author":"Krizek","year":"1999"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1753495X15598699","article-title":"Preconception counselling for women with acromegaly: More questions than answers","volume":"9","author":"Assal","year":"2016","journal-title":"Obstet Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/2042018815603927","article-title":"Pregnancy in acromegaly","volume":"6","author":"Laway","year":"2015","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad042","article-title":"Fertility in acromegaly: A single-center experience of female patients during active disease and after disease remission","volume":"108","author":"Pirchio","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0732","article-title":"The effect of treatment on quality of life in patients with acromegaly: a prospective study","volume":"182","author":"Wolters","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.733864\/full","article-title":"Variables associated with body image concerns in acromegaly patients: A cross-sectional study","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Psychol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4292\/wjgpt.v11.i2.17","article-title":"Gastrointestinal symptoms in acromegaly: A case control study","volume":"11","author":"Inayet","year":"2020","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"540398","DOI":"10.1155\/2012\/540398","article-title":"Clinical manifestations and diagnosis of acromegaly","volume":"2012","author":"Lugo","year":"2012","journal-title":"Int J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B56","article-title":"Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and\u00a0psychometric properties","volume-title":"Clinical Endocrinology","year":"2002"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01038-y","article-title":"An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies","volume":"23","author":"Fleseriu","year":"2020","journal-title":"Pituitary"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01206-2","article-title":"Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience","volume":"25","author":"Salvatori","year":"2022","journal-title":"Pituitary"},{"key":"B59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/eje.1.02312","article-title":"Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study","volume":"156","author":"Schreiber","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab874","article-title":"State of the art of patient-reported outcomes in acromegaly or GH deficiency: A systematic review and meta-analysis","volume":"107","author":"van der Meulen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41687-023-00541-7","article-title":"Development and evaluation of the acromegaly symptom diary","volume":"7","author":"Martin","year":"2023","journal-title":"J Patient-Rep Outcomes"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090358","article-title":"Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing","volume":"36","author":"Fries","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1177\/1073191111411667","article-title":"Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS\u00ae): depression, anxiety, and anger","volume":"18","author":"Pilkonis","year":"2011","journal-title":"Assessment"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-023-01314-7","article-title":"Evaluating the burden of endogenous Cushing\u2019s syndrome using a web-based questionnaire and validated patient-reported outcome measures","volume":"26","author":"Page-Wilson","year":"2023","journal-title":"Pituitary"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.05.010","article-title":"Pituitary tumors centers of excellence","volume":"49","author":"Frara","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of pituitary tumor centers of excellence (PTCOE): A\u00a0pituitary society statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary"},{"key":"B67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11102-024-01397-w","article-title":"Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)","volume":"27","author":"Giustina","year":"2024","journal-title":"Pituitary"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1516131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T05:12:35Z","timestamp":1738559555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1516131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":67,"alternative-id":["10.3389\/fendo.2025.1516131"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1516131","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"article-number":"1516131"}}